021-51111890
购物车（）
sales@molnova.cn
PF-1355
CAS No. 1435467-38-1
PF-1355 ( PF-06281355; PF 06281355; ZINC205721785 )
产品货号. M28021 CAS No. 1435467-38-1
PF-1355 is a selective 2-thiouracil mechanism-based MPO inhibitor. PF-1355 is used for treatment of vasculitic diseases.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥356 | 有现货 |
|
| 5MG | ￥583 | 有现货 |
|
| 10MG | ￥988 | 有现货 |
|
| 25MG | ￥1604 | 有现货 |
|
| 50MG | ￥3013 | 有现货 |
|
| 100MG | ￥4350 | 有现货 |
|
| 200MG | ￥6221 | 有现货 |
|
| 500MG | ￥9315 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PF-1355
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述PF-1355 is a selective 2-thiouracil mechanism-based MPO inhibitor. PF-1355 is used for treatment of vasculitic diseases.
-
产品描述PF-1355 is a selective 2-thiouracil mechanism-based MPO inhibitor. PF-1355 is used for treatment of vasculitic diseases.(In Vitro):PF-1355 inhibits MPO activity in phorbol ester-stimulated human neutrophils as measured by taurine chlorination (EC50=1.47 μM) as well as lipopolysaccharide-treated human blood measuring residual MPO activity (EC50=2.03 μM) .(In Vivo):Oral administration of PF-1355 reduces plasma MPO activity, vascular edema, neutrophil recruitment, and elevates circulating cytokines. In a model of anti-glomerular basement membrane disease, albuminuria and chronic renal dysfunction are completely suppressed by PF-1355 treatment .
-
同义词PF-06281355; PF 06281355; ZINC205721785
-
通路Others
-
靶点Other Targets
-
受体Antifungal
-
研究领域——
-
适应症——
化学信息
-
CAS Number1435467-38-1
-
分子量321.4
-
分子式C14H15N3O4S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C1C=C(C=2C=C(OC)C=CC2OC)N(C(=S)N1)CC(=O)N
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Prats E, et al. Antifungal activity of a new phenolic compound from capitulum of a head rot-resistant sunflower genotype. J Chem Ecol.?2007 Dec;33(12):2245-53. Epub 2007 Nov 22.
产品手册
关联产品
-
Giganteone A
The herbs of Curcuma wenyujin Y.H.Chen & C.Ling.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Moracin O
Moracin O shows significant neuroprotective, and analgesic activities, it also has a strong protective influence against doxorubicin-induced cardiomyopathy in H9c2 cells with the EC50 value of 4.5 ± 1.3 μM.
